Soluble Programmed Death-Ligand 1 (sPD-L1) as a Novel Biomarker for the Combination of Anti-PD-L1 Antibody and Radiotherapy for Glioma Patients
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS(2021)
Abstract
X. Ding: None. Z. Zhou: None. Z. Ge: None. Y. Guo: None. Y. Chen: None. S. Nie: None. J. Yu: None. M. Hu: None.
MoreTranslated text
Key words
glioma,novel biomarker,death-ligand,anti-pd-l
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined